Journal of

Case Reports and Images in Obstetrics and Gynecology

 
     
Case Report
 
A case of chronic myelogenous leukemia treated with different medication in each of the two pregnancies
Malak Alshammari1, Ghazi Sindi1, Abdullah Khaled Agabawi2, Estabrq Al Hachim3, Hassan S.O. Abduljabbar4
1MBBCH, Intern in Obstetrics and Gynecology department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
2MBBCH, Abdulaziz University Hospital, Jeddah, Saudi Arabia
3MBBCH, ABOG, Assistant Professor and Consultant, Department of Obstetrics & Gynecology, Medical College, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
4MD, FRCS, Professor and Consultant, Department of Obstetrics & Gynecology, Medical College, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia

Article ID: 100029Z08MA2017
doi:10.5348/Z08-2017-29-CR-9

Address correspondence to:
Hassan S.O. Abduljabbar MD
FRCS; Professor and Consultant, Department of Obstetrics & Gynecology
Medical College, King Abdulaziz University
P.O. Box 80215 Jeddah 21452
Kingdom of Saudi Arabia

Access full text article on other devices

  Access PDF of article on other devices

[HTML Full Text]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]

How to cite this article:
Alshammari M, Sindi G, Agabawi AK, Al Hachim E, Abduljabbar HSO. A case of chronic myelogenous leukemia treated with different medication in each of the two pregnancies. J Case Rep Images Obstet Gynecol 2017;3:38–42.


ABSTRACT
The simultaneous occurrence of pregnancy in case of chronic myelogenous leukemia is relatively uncommon. We describe successful management of chronic myelogenous leukemia (CML) in a 24-year-old woman in her first and second pregnancies using different medications. In her first pregnancy, she was started on PEG-interferon and delivered a baby girl in good condition at 40th week. After seven months she again got pregnant with twin pregnancy and was managed by hydroxyurea. She delivered twin girls in good condition by spontaneous vaginal delivery at 38th week.

Keywords: Chronic myelogenous leukemia, Hydroxyurea, PEG-Interferon, Pregnancy


[HTML Full Text]   [PDF Full Text]

Author Contributions
Malak Alshammari – Substantial contributions to conception and design, Revising it critically for important intellectual content, Final approval of the version to be published
Ghazi Sindi – Substantial contributions to conception and design, Drafting the article, Final approval of the version to be published
Abdullah Khaled Agabawi – Substantial contributions to conception and design, Drafting the article, Final approval of the version to be published
Estabrq Al Hachim – Substantial contributions to conception and design, Revising it critically for important intellectual content, Final approval of the version to be published
Hassan S.O. Abduljabbar – Substantial contributions to conception and design, Drafting the article, Final approval of the version to be published
Guarantor of submission
The corresponding author is the guarantor of submission.
Source of support
None
Conflict of interest
Authors declare no conflict of interest.
Copyright
© 2017 Malak Alshammari et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.



  Home line About the Journal line Aim and Scope line Open Access line Archives
Apply as Editor line Apply as Reviewer line Submit Reviews - Editors line Submit Reviews - Reviewers
Instructions for Authors line Templates to Use line Copyright Form line Author Checklist
Online Submission line Email Submission line Submit Revision line Submit All Forms line Submit Page Proofs
Terms of Service line Privacy policy line Disclaimer line FAQ line Contact: Journal line Contact: Edorium Journals line Site Map
 
  Copyright © 2017. Edorium. All rights reserved.